![]() |
市場調查報告書
商品編碼
2178810
血糖值支持補充劑市場預測至 2034 年—按產品類型、產品形式、應用、分銷管道、最終用戶、消費者年齡層和地區進行全球分析。Blood Sugar Support Supplements Market Forecasts to 2034 - Global Analysis By Product Type, Product Form, Application, Distribution Channel, End User, Consumer Age Group, and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球血糖值支持補充劑市場將達到 19 億美元,並在預測期內以 10.4% 的複合年成長率成長,到 2034 年達到 42 億美元。
血糖值支持補充劑是一種可口服的膳食補充劑,旨在支持血糖值在正常範圍內的健康代謝。這些產品含有小檜鹼、甲吡啶甲酸鉻、肉桂萃取物和α-硫辛酸等成分,這些成分被認為參與碳水化合物代謝、胰島素敏感性和餐後血糖反應。這些補充劑有膠囊、片劑、粉劑、軟糖和滴劑等多種形式,適合注重健康的消費者、活躍的成年人和老年人每日服用,以支持血糖代謝、餐後營養補充、碳水化合物代謝和整體代謝健康。
對代謝健康的認知
消費者對血糖值波動及其與能量快速下降、食慾增加和長期健康問題之間聯繫的認知不斷提高,推動了對代謝支持補充劑的需求。持續血糖監測(SGL)的廣泛應用使餐後血糖值反應更加清晰可見,從而能夠進行針對性干預。這促使消費者在改善飲食的同時尋求營養支持。在此背景下,小檜鹼和鉻的知名度不斷提升,促進了試用和重複購買。各大品牌正利用與穿戴式裝置和教育內容的整合來建立可信賴的品牌定位,從而在藥局和專業膳食補充品銷售管道保持持續成長。
藥物交互作用和標籤限制
某些有助於調節血糖值的成分,特別是小檁鹼,會與處方藥(例如降血糖藥和降血壓藥)發生相互作用,因此標籤上必須包含警告,限制正在服用這些藥物的消費者使用此類成分。監管機構正在嚴格審查暗示其能夠治療或預防糖尿病的宣傳,限制可接受的表達方式,並使跨司法管轄區的行銷變得更加複雜。這些限制縮小了目標客戶群體,增加了法律審查成本,同時,針對特定市場的標籤法規也減緩了膳食補充劑生產商的國際擴張,並使品牌訊息的傳播變得更加困難。
個性化與穿戴式裝置結合
隨著持續血糖監測在一般健康管理中日益普及,品牌有機會將營養補充劑與數據驅動的指導和個人化劑量建議相結合。監測餐後血糖值的消費者更願意投資於能帶來可衡量效果的產品。與追蹤應用程式整合的訂閱模式鼓勵用戶持續使用,並帶來持續的收入。隨著穿戴式裝置的普及,其應用範圍將超越糖尿病管理,血糖值支持補充劑將能夠透過D2C(直接面對消費者)和診所管道觸及更廣泛的消費群體,並利用數據進行推廣。
飲食療法的替代方案
低碳水化合物飲食、間歇性斷食和結構化運動正在降低消費者購買營養補充劑的意願,因為這些方法無需服用補充劑即可帶來可衡量的代謝改善。許多消費者認為生活方式的改變比藥物更有效,尤其是在營養補充劑的臨床證據仍然有限的情況下。隨著功能性食品和飲料品牌在其主流產品中加入血糖值管理功能,對營養補充品的需求可能會進一步放緩。因此,供應商必須證明其產品具有互補價值和可衡量的效果,才能證明其定價的合理性並維持消費者的重複購買。
新冠疫情凸顯了代謝健康不良與嚴重後果之間的關聯,促使人們更加關注代謝風險因子。疫情期間,消費者紛紛上網搜尋如何控制血糖和增強免疫力,這推動了代謝補充劑在電商平台上的早期普及。疫情過後,人們對穿戴式監測設備和預防性健康管理的持續興趣進一步刺激了市場需求,同時各大品牌加大了對臨床證據的投入,並拓展了產品線,推出了軟糖和粉劑等便捷劑型,以鼓勵消費者持續使用。
在預測期內,小蘗鹼產品細分市場預計將佔據最大的市場佔有率。
預計在預測期內,小檜鹼產品將佔據最大的市場佔有率,這主要得益於消費者對小檜鹼的高認知度、對葡萄糖代謝的廣泛研究興趣以及透過藥局和電商通路的廣泛供應。小蘗鹼易於製成膠囊和片劑,這有利於擴大分銷範圍並確保劑量穩定。尋求天然代謝支持的消費者通常會先嘗試小檜鹼,這促進了試用和重複購買。隨著人們對代謝的關注度不斷提高,預計小檜鹼將繼續保持其在該類別中的旗艦產品地位,並維持其領先的銷售佔有率。
預計在預測期內,軟糖細分市場將呈現最高的複合年成長率。
在預測期內,軟糖產品預計將呈現最高的成長率,這主要得益於消費者對便捷美味形式的偏好,這種形式有助於提高年輕消費者的每日攝取量。軟糖可以緩解“片劑疲勞”,支持訂閱模式,同時也能讓品牌將鉻、肉桂和α-硫辛酸等成分組合在單一產品中。隨著配方研發人員不斷提高軟糖基質中活性成分的含量,並改進口味掩蔽技術,以及藥局和電商通路新產品的激增,軟糖產品有望成為成長最快的產品形式。
在整個預測期內,北美預計將保持最大的市場佔有率,這得益於其對代謝健康的高度重視、穿戴式設備的普及以及藥店和專賣銷售管道中豐富的黃連素和鉻產品的供應。美國正引領區域銷售,這得益於各大品牌對經臨床驗證和資料整合專案的投入。代謝健康領域新創企業的積極創業融資以及膳食補充劑成熟的通路進一步鞏固了該地區的領先地位。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於人們對代謝健康的日益關注、中產階級消費的不斷成長,以及小檜鹼和肉桂補充劑在中國、印度、日本和韓國日益普及。消費者正積極採用代謝支持產品,本土品牌也拓展產品線,推出軟糖和粉末等劑型。電子商務滲透率的提高和藥局網路的擴張進一步推動了這些產品的普及,使亞太地區成為血糖值支持補充劑成長最快的區域市場。
北美洲
我們
加拿大
墨西哥
歐洲
英國
德國
法國
義大利
西班牙
荷蘭
比利時
瑞典
瑞士
波蘭
其他歐洲國家
亞太地區
中國
日本
印度
韓國
澳洲
印尼
泰國
馬來西亞
新加坡
越南
亞太其他地區
南美洲
巴西
阿根廷
哥倫比亞
智利
秘魯
南美洲其他地區
世界其他地區(RoW)
中東
沙烏地阿拉伯
阿拉伯聯合大公國
卡達
以色列
其他中東國家
非洲
南非
埃及
摩洛哥
其他非洲國家
企業概況
對其他市場參與者(最多 3 家公司)進行全面分析
對主要公司進行SWOT分析(最多3家公司)
區域細分
根據客戶的興趣,我們將提供主要國家的市場估算和預測,以及複合年成長率(註:需經可行性確認)。
競爭性標竿分析
According to Stratistics MRC, the Global Blood Sugar Support Supplements Market is accounted for $1.9 billion in 2026 and is expected to reach $4.2 billion by 2034 growing at a CAGR of 10.4% during the forecast period. Blood sugar support supplements are ingestible nutritional products formulated to support glucose handling and metabolic wellness within normal ranges. They contain berberine, chromium picolinate, cinnamon extract, and alpha-lipoic acid, which are associated with carbohydrate metabolism, insulin sensitivity, and post-meal glucose response. These supplements are delivered as capsules, tablets, powders, gummies, and liquid drops, and are consumed daily by general wellness buyers, active adults, and older adults seeking glucose metabolism support, post-meal nutrition support, carbohydrate metabolism, and overall metabolic wellness.
Metabolic Health Awareness
Growing consumer awareness of blood sugar variability and its connection to energy crashes, cravings, and long-term health is driving demand for metabolic support supplements. Continuous glucose monitoring adoption has made post-meal responses visible and actionable, encouraging buyers to seek nutritional support alongside dietary change. Berberine and chromium carry established recognition in this context, which supports trial and repeat purchase. Brands leverage wearable integration and educational content to build credible positioning, thereby sustaining growth across pharmacy and specialty supplement channels.
Drug Interaction and Claim Constraints
Several blood sugar support ingredients, particularly berberine, interact with prescription medications such as glucose-lowering and antihypertensive drugs, requiring label warnings that limit use among medicated consumers. Authorities scrutinize claims implying treatment or prevention of diabetes, which restricts permissible language and complicates marketing across jurisdictions. These constraints reduce the addressable population and increase legal review costs, while inconsistent labeling rules across markets slow international expansion and complicate brand messaging for supplement manufacturers.
Wearable-Integrated Personalization
The spread of continuous glucose monitors into general wellness creates opportunity for brands to pair supplements with data-driven guidance and personalized dosing recommendations. Consumers who observe post-meal glucose responses are more willing to invest in products positioned around measurable outcomes. Subscription models integrated with tracking applications reinforce adherence and generate recurring revenue. As wearable adoption expands beyond diabetes management, blood sugar support supplements can capture a larger, data-engaged consumer base across direct-to-consumer and clinic channels.
Substitution by Dietary Approaches
Low-carbohydrate eating, intermittent fasting, and structured exercise deliver measurable metabolic improvements without supplementation, which reduces willingness among motivated consumers to purchase products. Many buyers perceive lifestyle change as more effective than pills, particularly where clinical evidence for supplements remains modest. If functional food and beverage brands add blood sugar positioning to mainstream products, supplement demand may soften further. Consequently, providers must demonstrate complementary value and measurable outcomes to defend pricing and sustain repeat purchase.
The pandemic heightened attention to metabolic risk factors, as poor metabolic health was associated with severe outcomes. During the crisis, consumers researched glucose control and immune resilience online, supporting early adoption of metabolic supplements through e-commerce. Post-pandemic, sustained interest in wearable monitoring and preventive wellness has reinforced demand, while brands invested in clinical substantiation and expanded convenient formats such as gummies and powders to improve adherence.
The Berberine Products segment is expected to be the largest during the forecast period
The Berberine Products segment is expected to account for the largest market share during the forecast period, due to strong consumer recognition, extensive research attention on glucose metabolism, and broad availability across pharmacy and e-commerce channels. Berberine integrates easily into capsules and tablets, which supports distribution scale and consistent dosing. Consumers seeking natural metabolic support frequently begin with berberine, which drives trial and repeat purchase. As metabolic awareness expands, berberine remains the category anchor, thereby sustaining leading revenue share.
The Gummies segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Gummies segment is predicted to witness the highest growth rate, driven by consumer preference for convenient, pleasant-tasting formats that improve daily adherence among younger buyers. Gummies reduce pill fatigue and support subscription models, while allowing brands to combine chromium, cinnamon, and alpha-lipoic acid in a single serving. As formulators improve active loading and taste masking in gummy matrices, launches multiply across pharmacy and e-commerce channels, making this the fastest-growing product form segment.
During the forecast period, the North America region is expected to hold the largest market share, due to high metabolic health awareness, widespread wearable adoption, and strong availability of berberine and chromium products across pharmacy and specialty channels. The United States dominates regional revenue, supported by brands investing in clinical substantiation and data-integrated programs. Active venture funding for metabolic wellness startups and established dietary supplement pathways further reinforce the region's leading position.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly rising metabolic health concerns, expanding middle-class spending, and growing adoption of berberine and cinnamon supplements across China, India, Japan, and South Korea. Consumers readily adopt metabolic support products, while local brands expand gummy and powder formats. Growing e-commerce penetration and pharmacy networks further support adoption, making Asia Pacific the fastest-growing regional market for blood sugar support supplements.
Key players in the market
Some of the key players in Blood Sugar Support Supplements Market include Nestle S.A., Danone S.A., Abbott Laboratories, Amway Corporation, Herbalife Ltd., USANA Health Sciences, Inc., Nature's Sunshine Products, Inc., Jamieson Wellness Inc., Haleon plc, Bayer AG, Glanbia plc, Blackmores Limited, NOW Health Group, Inc., Thorne HealthTech, Inc., Pharmavite LLC, and Swisse Wellness Pty Ltd.
In October 2026, Thorne HealthTech, Inc. launched a berberine and chromium picolinate capsule formulated for glucose metabolism support, supported by clinical testing and distributed through practitioner channels and brand-owned e-commerce across North America.
In September 2026, Pharmavite LLC expanded its metabolic wellness portfolio with cinnamon extract and alpha-lipoic acid gummies positioned for post-meal nutrition support, targeting general wellness buyers through pharmacies and online marketplaces.
In August 2026, Blackmores Limited introduced blood sugar support powders and capsules formulated for carbohydrate metabolism, distributed through specialty retailers and e-commerce platforms with practitioner education across Australia and Southeast Asia.
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Netherlands
Belgium
Sweden
Switzerland
Poland
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Thailand
Malaysia
Singapore
Vietnam
Rest of Asia Pacific
South America
Brazil
Argentina
Colombia
Chile
Peru
Rest of South America
Rest of the World (RoW)
Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
Africa
South Africa
Egypt
Morocco
Rest of Africa
Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.